Live feed09:31:00·42dPRReleasevia QuantisnowAgios Submits sNDA to FDA for U.S. Accelerated Approval of Mitapivat in Sickle Cell DiseaseByQuantisnow·Wall Street's wire, on your screen.AGIO· Agios Pharmaceuticals Inc.Health Care
